ProRelix Education Revenue and Competitors

Pune, IND

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ProRelix Education's estimated annual revenue is currently $2.1M per year.(i)
  • ProRelix Education's estimated revenue per employee is $77,500

Employee Data

  • ProRelix Education has 27 Employees.(i)
  • ProRelix Education grew their employee count by -4% last year.

ProRelix Education's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M155-4%N/AN/A
#2
$17.3M22318%N/AN/A
#3
$11.1M14334%N/AN/A
#4
$8.2M1068%N/AN/A
#5
$9.5M12310%N/AN/A
#6
$21.2M2738%N/AN/A
#7
$12M1558%N/AN/A
#8
$18.9M2445%N/AN/A
#9
$12.5M1619%N/AN/A
#10
$20.5M2648%N/AN/A
Add Company

What Is ProRelix Education?

ProRelix Education (ProRelix Services LLP), India was established in the year 2014. Today, ProRelix Education remains as one of the leading Management, Life sciences, Healthcare and related training organisation in India. ProRelix Education (ProRelix Services LLP) is an Institute for Management, Clinical Research & Regulatory Affairs in India. We are an innovative Education Institute established to provide excellent professional education courses/programs in Management, Clinical Research, Pharmaceutical, Biotechnology & Healthcare etc. We value innovation, excellence, passion and respect; and providing training solutions to the students from all the educational and professional backgrounds in India and other part of the world. We are committed to: - Provide continuing education, professional development and short term skills enhancement program. - Help to achieve the level of expertise required through user-friendly, industry oriented and cost effective training programs.

keywords:N/A

N/A

Total Funding

27

Number of Employees

$2.1M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M270%N/A
#2
$3.1M274%N/A
#3
$2.7M27N/AN/A
#4
$2.4M2723%N/A
#5
$2.1M270%N/A